Parkinson's Disease Trial, Recruiting (NCT06998303)

Parkinson's Disease Trial, Recruiting NCT06998303 Sponsor: University of Minnesota Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06998303 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 21 years of age or older
You have a specific type of deep brain stimulation (DBS) device already implanted (a Medtronic Percept or Percept RC system) that is safe to use with MRI scans, placed there to treat Parkinson's disease
You speak English

Who may not be able to join:

You are not able to give your own consent to participate in the trial
Your implanted DBS device is not safe or compatible for use with MRI scans
You are pregnant
You have severe claustrophobia (intense fear of enclosed spaces)
You have any medical reason why you should not have an MRI scan (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06998303

Sponsor: University of Minnesota

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

More information: https://clinicaltrials.gov/study/NCT06998303

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 21 years of age or older
You have a specific type of deep brain stimulation (DBS) device already implanted (a Medtronic Percept or Percept RC system) that is safe to use with MRI scans, placed there to treat Parkinson's disease
You speak English

Who may not be able to join:

You are not able to give your own consent to participate in the trial
Your implanted DBS device is not safe or compatible for use with MRI scans
You are pregnant
You have severe claustrophobia (intense fear of enclosed spaces)
You have any medical reason why you should not have an MRI scan (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

31 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Blood Oxygen-Level Dependent (BOLD) signal in leg region of primary motor cortex

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov